爱小
Lv1
40 积分
2022-03-01 加入
-
Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ‐12420), a novel potassium‐competitive acid blocker, in healthy male subjects
17天前
已完结
-
Gastrointestinale Blutung im Alter
20天前
已完结
-
The associations among peptic ulcer disease, Helicobacter pylori infection, and abdominal aortic aneurysms: A nationwide population-based cohort study
20天前
已完结
-
Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials
28天前
已完结
-
Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials
28天前
已完结
-
Latin American consensus on diagnosis of gastroesophageal reflux disease
1个月前
已完结
-
Exploring the impact of short-acting GLP-1 receptor agonists on GERD risk
1个月前
已完结
-
Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysis
1个月前
已完结
-
Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial
1个月前
已完结
-
Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects
2个月前
已完结